Wealth Enhancement Advisory Services’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,629
Closed -$201K 4205
2026
Q1
$201K Sell
3,629
-1,890
-34% -$90K ﹤0.01% 3129
2025
Q4
$218K Buy
+5,519
New +$224K ﹤0.01% 3202

Other funds holding PAHC

Wealth Enhancement Advisory Services's PAHC Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 3,629 shares — an estimated $201K sold.

Wealth Enhancement Advisory Services first reported a position in PAHC in Q4 2025 and held it in 2 quarters. The position peaked at $218K in Q4 2025. 27 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Wealth Enhancement Advisory Services reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 3,629 Phibro Animal Health shares in Q2 2026, an estimated $201K.
  • Wealth Enhancement Advisory Services first reported a position in Phibro Animal Health in Q4 2025 and held it in 2 quarters.
  • Wealth Enhancement Advisory Services's Phibro Animal Health position peaked at $218K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.